Extra-cardiac impedance based hemodynamic assessment method and system
AssigneePacesetter, Inc.
InventorsGene A. Bornzin, Xiaoyi Min
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorsGene A. Bornzin, Xiaoyi Min
Estimating the term…
A medical device is provided that comprises a lead assembly configured to be at least partially located proximate to the heart. The lead assembly includes an extra-cardiac (EC) electrode to be positioned proximate to at least one of a superior vena cava (SVC) and a left ventricle (LV) of a heart. The lead assembly includes a subcutaneous remote-cardiac (RC) electrode configured to be located remote from the heart such that at least a portion of the greater vessels are interposed between the RC electrode and the EC electrode to establish an extra-cardiac impedance (ECI) vector. The processor module measures extra-cardiac impedance along the ECI vector to obtain ECI measurements. The processor module assesses a hemodynamic performance based on the ECI measurements.
A medical device comprising:
A method for assessing hemodynamic stability, comprising:
Dependencies are inferred from the claim text.